We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Biotech Growth Trust (the) Plc | LSE:BIOG | London | Ordinary Share | GB0000385517 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-21.00 | -2.32% | 885.00 | 880.00 | 883.00 | 901.00 | 880.00 | 901.00 | 76,716 | 16:35:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 80.35M | 74.6M | 2.3339 | 3.77 | 289.59M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/2/2017 12:24 | If you really believe that stuff you will go leveraged long I guess. But personally I can not see how a chart can predict a fund like this! | shaker44 | |
28/2/2017 10:39 | If we can breakout and establish ourselves above 765p we have a technical inverse head and shoulder medium term target of circa 980-1000p | powersno1 | |
18/1/2017 09:10 | Now it's 10% discount to nav. Biog should now be buying their own shares back, let's see..... | earthmanian | |
04/1/2017 15:40 | Still a bit of a discount actually esp with the continuing US biotech rallies, for the moment anyway. | hutch_pod | |
04/1/2017 10:27 | IBT has narrowed as well to 10%. | philo124 | |
04/1/2017 09:39 | Any ideas as to why the share is now trading around its NAV. For the last few years the share has been trading at a discount to its NAV of about 5% ? | earthmanian | |
09/11/2016 19:43 | So with Brexit and US Elections done and dusted, maybe a few months of mergers, acquisitions and cancer treatment successes can see this move quickly up to £8 especially now no government meddling in price structures. A great day! | earthmanian | |
09/11/2016 17:53 | I think we deserve today after enduring the last year or so... | bigwilly1986 | |
09/11/2016 17:04 | Cracking timing. Esp as seemed most of the Clinton bad news was baked in already | hutch_pod | |
09/11/2016 16:01 | once in a blue moon bit of good timing! | harry the haddock | |
09/11/2016 15:44 | Well done! | philo124 | |
09/11/2016 15:42 | especially when i bought yesterday at 630! | harry the haddock | |
09/11/2016 15:34 | Happy day. | philo124 | |
22/8/2016 09:12 | Great, thanks. | philo124 | |
22/8/2016 09:10 | Interesting to note that Bio bought back 285k shares @7.10 on Friday. And today news of 2 mega deals in the sector with potential chinese buyers. Onwards and upwards... | shaker44 | |
03/7/2016 10:10 | Holding up well. | philo124 | |
16/2/2016 09:58 | why did it cheer you up Hutch? whe is a good time to add? | ali47fish | |
05/2/2016 10:56 | This cheered me up Gilead Reports Record Results, Street Remains Bored: Why? What's Next? | hutch_pod | |
03/2/2016 14:01 | Oh dear. Biotech going down the drain. Needs some stimulation from somewhere. | terry barnett | |
31/1/2016 07:51 | > Earthmanian 21 Jan'16 - 13:51 - 257 of 259 0 0 > > No death crosses here Jimbo I count three on the chart I posted a link to: 1. 50 Day EMA breach of 100 day EMA: September 2015 2. 50 Day EMA breach of 200 day EMA: October 2015 3. 100 Day EMA breach of 200 day EMA: Late October 2015 Personally, (2) would have had me out of here at just shy of £7.50 per share if I'd held. Would recommend taking a look at death crosses on Gold in 2013. Personally I think these signals are a great trend change risk management tool that can get you out of the way of the worst of a long bear phase, but each to their own... | jimbo55 | |
28/1/2016 16:05 | Lowest point in 12 mo | robotface | |
21/1/2016 17:00 | Agree, very good lth. But I have traded a few, usually reaches a high towards the end of july. | philo124 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions